Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon ...

The CDC announced on April 1 that they would be downsizing their operations, leading to the pause of diagnostic testing for mpox, rabies, and more than 2 dozen other infectious diseases. 1 The CDC has ...

Conclusions: Our findings suggest that Medicare inpatient encounters are associated with higher coding intensity than ...

Adults can take the CAR T-cell therapy for relapsed or refractory mantle cell lymphoma after the full approval of the ...

A global cohort has tracked pediatric HIV growth after dolutegravir, showing early catch-up weight gain, then stable BMI ...

At the American Academy of Dermatology (AAD) 2026 Annual Meeting, experts emphasized the value of in-person networking, ...

Conclusions: Prevalence of obesity is increasing, and use of GLP-1 RAs as the preferred antiobesity medication has increased ...

Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack ...

HB 4965 permits switching to an alternative medically appropriate treatment of equal or lesser value after initial approval, ...

ATTAIN demonstrated placebo-adjusted weight reductions of roughly 9–11 percentage points at 72 weeks, with 27.3 lb (12.4%) ...

The ongoing disruption in the Middle East is affecting a meaningful portion of global clinical research, with 6.7% of active ...

“Interestingly, BIRC5 and MCL-1 have both been reported to be over-expressed and strongly correlated with progression and ...